Wolverine Asset Management’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Wolverine Asset Management’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,302	Closed	-$368	–	2081
2023 Q1	$368	Sell	19,302 -8,897	-32%	-$857	﹤0.01%	1775
2022 Q4	$4.2K	Sell	28,199 -3,786	-12%	-$605	﹤0.01%	1770
2022 Q3	$5K	Sell	31,985 -4,564	-12%	-$669	﹤0.01%	2163
2022 Q2	$4K	Sell	36,549 -774	-2%	-$383	﹤0.01%	2166
2022 Q1	$29K	Sell	37,323 -4,449	-11%	-$3.11K	﹤0.01%	1686
2021 Q4	$25K	Buy	+41,772	New	+$42.4K	﹤0.01%	1671

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Wolverine Asset Management's PEARW Position: Q2 2023 in Review

Wolverine Asset Management sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 19,302 shares — an estimated $368 sold.

Wolverine Asset Management first reported a position in PEARW in Q4 2021 and held it in 6 quarters. The position peaked at $29K in Q1 2022. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Wolverine Asset Management reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Wolverine Asset Management sold 19,302 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $368.
Wolverine Asset Management first reported a position in Pear Therapeutics, Inc. Warrant in Q4 2021 and held it in 6 quarters.
Wolverine Asset Management's Pear Therapeutics, Inc. Warrant position peaked at $29K in Q1 2022.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.